A one-minute look back at the week of February 2, 2015, in managed care, including another top resignation from a federal agency and budget proposals affecting Medicare and Medicaid.
FDA Commissioner Margaret Hamburg, MD, announced her resignation this week, causing speculation that Robert Califf, MD, a new arrival to the agency from Duke University will be her replacement.
President Barack Obama’s budget will squeeze money from Medicaid and Medicare, but he also called for Medicare to negotiate specialty drug prices.
Lastly, if you missed our Patient-Centered Oncology Care meeting in Baltimore, November 2014, you can watch video segments from the meeting on the Patient-Centered Oncology Care 2014 page.
Read more:
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen